Details for New Drug Application (NDA): 020764
✉ Email this page to a colleague
The generic ingredient in LAMICTAL CD is lamotrigine. There are thirty-two drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lamotrigine profile page.
Summary for 020764
Tradename: | LAMICTAL CD |
Applicant: | Glaxosmithkline Llc |
Ingredient: | lamotrigine |
Patents: | 0 |
Pharmacology for NDA: 020764
Mechanism of Action | Dihydrofolate Reductase Inhibitors Organic Cation Transporter 2 Inhibitors |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 020764
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LAMICTAL CD | lamotrigine | TABLET, FOR SUSPENSION;ORAL | 020764 | NDA | GlaxoSmithKline LLC | 0173-0526 | 0173-0526-00 | 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0526-00) |
LAMICTAL CD | lamotrigine | TABLET, FOR SUSPENSION;ORAL | 020764 | NDA | GlaxoSmithKline LLC | 0173-0527 | 0173-0527-00 | 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0527-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 5MG | ||||
Approval Date: | Aug 24, 1998 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 25MG | ||||
Approval Date: | Aug 24, 1998 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | 100MG | ||||
Approval Date: | Aug 24, 1998 | TE: | RLD: | No |
Expired US Patents for NDA 020764
Complete Access Available with Subscription